Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France
Listen to Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.
Decera Clinical Education Oncology Podcast · Alain Ravaud MD PhD, Marine Gross-Goupil MD PhD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest immuno-oncology developments in the treatment of urothelial cancer.
Presenters:
Alain Ravaud, MD, PhD
Professor of Medical Oncology
Head of Department of Medical Oncology
Bordeaux University Hospital
Bordeaux, France
Marine Gross-Goupil, MD, PhD
Medical Oncologist
Saint-André Hospital
Bordeaux University Hospital
Bordeaux, France
Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.
Link to full program:
https://bit.ly/3kJC5SL
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.